Total Knee Arthroplasty Clinical Trial
— KNEE BDNFOfficial title:
Postoperative Painful Chronicization After Knee Replacement Surgery : Exploratory Study of BDNF's Kinetics
Verified date | May 2024 |
Source | University Hospital, Montpellier |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Chronic pain is an extremely disabling disease. It is a major public health problem due to the lack of effective therapy. Chronic postoperative pain (CPOP) is defined by a painful symptomatology in the operated area unrelated to previous pain, present for more than 3 months, and without any link to surgical complication. The prevalence of chronicization of postoperative pain is 30% after total knee arthroplasty. Identification of clinical, biological and psychological profiles are crucial to prevent CPOP. A biologic factor, Brain Derived Neurotrophic Factor (BDNF) produced by a variety of cells is a key regulator of neuroplasticity. BDNF is increasingly studied in the mechanisms of cerebral sensitization and pain chronicization. The role of BDNF in pain of patients remains to be explored in a prospective study. The aim of this observational study is to compare the kinetics of BDNF after total knee arthroplasty in patients with and without CPOP. Patients will be included in the study at the preanesthetic consultation. Serum BDNF levels will be measured preoperatively, 48h postoperatively, 3 and 6 months after surgery.
Status | Active, not recruiting |
Enrollment | 200 |
Est. completion date | July 2, 2024 |
Est. primary completion date | December 2, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Social security affiliation - Adult patients - Signed informed consent - Score ASA (American Society of Anesthesiology) 1-3 - Total knee arthroplasty Exclusion Criteria: - Patient unable to exercise consent - Pregnant women - Vulnerable people - Patients not included in the postoperative rehabilitation program - Patients unable to complete the pain assessment questionnaires - Chronic pain patients (other than knee arthrosis) - Neuropathic pain patients (beforehand) - Inflammatory diseases, progressive cancer, sepsis, immunosuppression known |
Country | Name | City | State |
---|---|---|---|
France | Department of Anesthesiology and critical care, Lapeyronie University Hospital | Montpellier |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Montpellier | Institut National de la Santé Et de la Recherche Médicale, France |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | BDNF level | assessed by ELISA technique | preoperative to 6 months after surgery | |
Secondary | Pain level | evaluated by Visual Analog Scale (VAS) | preoperative to 6 months after surgery | |
Secondary | Neuropathic pain diagnostic | evaluated by neuropathic pain diagnostic questionnaire (DN4) | preoperative to 6 months after surgery | |
Secondary | Postoperative rehabilitation | evaluated by the Brief Pain Questionary (BPI) | preoperative to 6 months after surgery | |
Secondary | Health related quality of life | evaluated by the SF-12 Health Survey | preoperative to 6 months after surgery | |
Secondary | Anxiety and Depression | evaluated by the Hospital Anxiety and Depression scale (HAD) | preoperative to 6 months after surgery | |
Secondary | Pain level perception | evaluated by the The pain Catastrophizing Scale | preoperative to 6 months after surgery | |
Secondary | Assessment of functional capacities in knee arthritis | evaluated by the Western Ontario and McMaster Universities Arthritis Index (WOMAC) | preoperative to 6 months after surgery | |
Secondary | Oxidative stress marker | 8-iso-prostaglandin F2a level by biochemical labeling | preoperative to 6 months after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03542981 -
Interferential Current Therapy After Total Knee Arthroplasty
|
N/A | |
Recruiting |
NCT04458480 -
Effect of Fast Inpatient Rehabilitation After TKA
|
||
Completed |
NCT03286543 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
|
N/A | |
Recruiting |
NCT06061367 -
Muscles Strength and Gait Parameteres After TKA
|
||
Recruiting |
NCT05391828 -
Persona MC vs PS RCT With ROSA
|
N/A | |
Active, not recruiting |
NCT04850300 -
Efficiency Assessment of the Methodology for the Follow-up of Patients With Knee Prostheses
|
Phase 3 | |
Completed |
NCT05635916 -
Trial of Liposomal Bupivacaine for TKA
|
Phase 4 | |
Enrolling by invitation |
NCT05130216 -
Genicular Nerve Radiofrequency Ablation for Chronic Knee Pain After Total Knee Arthroplasty
|
||
Withdrawn |
NCT02495805 -
Ultrasound-guided Continuous Proximal Adductor Canal vs Continuous Femoral Nerve Block for Postoperative Pain Control and Rehabilitation Following Total Knee Arthroplasty
|
N/A | |
Completed |
NCT03206554 -
Local Infiltration Analgesia in Total Knee Arthroplasty
|
Phase 2 | |
Withdrawn |
NCT01511211 -
Duration of Leg Nerve Blocks With Dexamethasone Added to Local Anesthetic
|
Phase 4 | |
Completed |
NCT01616836 -
Optimizing Pain and Rehabilitation After Knee Arthroplasty
|
Phase 3 | |
Not yet recruiting |
NCT00958945 -
Retrospective Chart Analysis in the Effective Use of FloSeal in Post-Operative Joint Replacements
|
N/A | |
Completed |
NCT00985920 -
Topical Tranexamic Acid for Total Knee Arthroplasty
|
Phase 4 | |
Completed |
NCT00761956 -
A Study to Compare the NexGen CR and CR-Flex Knee Implants
|
N/A | |
Completed |
NCT03289247 -
Tissue Adhaesive in Wound Closure Following Primary Total Knee Arthroplasty
|
N/A | |
Terminated |
NCT03316118 -
US Guided GNB vs Saline Injection for TKA
|
Phase 4 | |
Recruiting |
NCT05962970 -
Continuous Adductor Canal Block in Fast Track Total Knee Arthroplasty
|
N/A | |
Completed |
NCT03317834 -
Navio With Total Knee Arthroplasty
|
||
Enrolling by invitation |
NCT06188091 -
Joint Movement to Increase Range of Motion in Knee Joint After Primary Total Knee Arthroplasty
|
N/A |